Red List

AVBPArriVent BioPharma, Inc.

Healthcare · Biotechnology · small-cap ($1.4B)
-53.5%
from rolling 252-day high of $35.83 set 2026-06-26 · 112d ago
Current
$16.66
Decline depth
-53.5%
Decline σ
4.3σ
TFC
2/5 bearish

Where it stands

On the Red List.

Down 53.5% from its rolling 252-day high, 112 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Tier and recovery signal are unchanged between these two observations.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

AVBP qualifies for the Red List on decline depth.

Down 53.5% from its rolling 252-day high, 112 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-53.5%
From rolling 252-day high of $35.83, 112d ago. Past the 40% Red List threshold.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
4.3σ
Drop over the last 20 bars in units of daily volatility (11.21%/day). Past the ≥4σ Watch threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Red List; recovery signal active → Red List
  2. Watch; recovery signal active → Red List; recovery signal active
  3. Watch → Watch; recovery signal active
  4. Unmatched; coverage or recovery unconfirmed → Watch
  5. Watch → Unmatched; coverage or recovery unconfirmed
  6. Unmatched; coverage or recovery unconfirmed → Watch
  7. Watch → Unmatched; coverage or recovery unconfirmed
  8. Unmatched; coverage or recovery unconfirmed → Watch
  9. Watch → Unmatched; coverage or recovery unconfirmed
  10. Unmatched; coverage or recovery unconfirmed → Watch
  11. Watch → Unmatched; coverage or recovery unconfirmed
  12. Unmatched; coverage or recovery unconfirmed → Watch

Showing the latest 12 of 19 recorded events.

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Around the worst days

What the news said when AVBP fell hardest.

News published within a day of its largest one-day drops points to a product or clinical-trial setback.

  • -47.0%
  • -15.0%
  • -5.5%

A language model's reading of 4 headlines, taken . It classifies the news on those days; it does not explain the whole decline and is not a tier input. How this is produced.

Technical interpretation and signal details

The structural read

What price action says about AVBP.

AVBP qualifies for the Red List on decline depth — down -53.5% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: decline sigma also reads 4.3σ over 20 bars.

Questions about AVBP

What people ask.

Why is AVBP on Broken Stocks?

AVBP qualifies for the Red List on decline depth. It is down -53.5% from its rolling 252-day high of $35.83, set on 2026-06-26 — 112d ago.

Is AVBP a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. AVBP is down -53.5% from its 52-week high of $35.83, set 112d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — the classification does not predict subsequent returns. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is AVBP a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is AVBP trading inside its 52-week range?

At $16.66, AVBP sits 0.0% of the way from its 52-week low ($17.00) to its 52-week high ($35.83). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has AVBP been declining?

The current 53.5% decline accrued over 112d, which annualizes to roughly -174.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does AVBP compare to its sector?

There are 408 other Healthcare tickers on Broken Stocks: 273 Red, 95 Amber, 40 Watch, with 178 showing recovering structural signals. Median sector decline is -37.5% — AVBP's decline is deeper than the sector median.